Regular blood testing for carcinoembryonic antigen (CEA, every 3‐ to 6 months) is currently the only blood test recommended for routine monitoring of CRC 7, 8, 9, 10, 11, 12, 13. Here, CEACAM5 is linked to colorectal carcinoma.